Will I regain weight when I stop semaglutide
Zepbound and Mounjaro are dual-agonist drugs and activate two receptors in the brain and throughout the body: GLP-1 and glucose-dependent insulinotropic polypeptide or GIP
To qualify, a person must be enrolled in a Medicare Part D plan and meet one of three clinical criteriaassessed at the time you first started GLP-1 therapy, not at the time you apply: BMI of 35 or higher (no additional diagnosis required) BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension on two or more blood pressure medications, or chronic kidney disease stage 3a or higher BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease Your provider submits a prior authorization request attesting you meet the criteriayou dont need to opt in or take any action yourself
the 23 month buffer accounts for metabolic adjustment and pregnancy test confirmation timing
When injected, Semaglutide targets receptors that slow digestion and decrease appetite, helping reduce calorie intake
